Alert: FDA Maintains Assigned Unique Suffixes in Generic Names forĀ Biologics

On January 12, 2017, the FDA issued its final guidance on generic naming for biological products submitted pursuant to 351(a) or (k) of the Public Health Service Act. The guidance is titled Nonproprietary Naming for Biological Products and maintains...
By: Cooley LLP

Cooley LLP